article · Urologic Oncology Seminars and Original Investigations

Optimal adjuvant intravesical therapy for intermediate risk non-muscle invasive bladder cancer; oncological and patient-reported outcomes of randomized controlled trial

2026Mansoura University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Bladder and Urothelial Cancer Treatments
Urinary Bladder and Prostate Research
Urinary and Genital Oncology Studies

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.urolonc.2026.111006

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.